HomeCompareFSGHF vs MRK

FSGHF vs MRK: Dividend Comparison 2026

FSGHF yields 2222.22% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FSGHF wins by $26607504688.20M in total portfolio value
10 years
FSGHF
FSGHF
● Live price
2222.22%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26607504688.26M
Annual income
$24,443,703,761,807,280.00
Full FSGHF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — FSGHF vs MRK

📍 FSGHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFSGHFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FSGHF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FSGHF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSGHF
Annual income on $10K today (after 15% tax)
$188,888.89/yr
After 10yr DRIP, annual income (after tax)
$20,777,148,197,536,188.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, FSGHF beats the other by $20,777,148,197,527,860.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSGHF + MRK for your $10,000?

FSGHF: 50%MRK: 50%
100% MRK50/50100% FSGHF
Portfolio after 10yr
$13303752344.16M
Annual income
$12,221,851,880,908,540.00/yr
Blended yield
91.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FSGHF
No analyst data
Altman Z
1.9
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSGHF buys
0
MRK buys
0
No recent congressional trades found for FSGHF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFSGHFMRK
Forward yield2222.22%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$26607504688.26M$56.8K
Annual income after 10y$24,443,703,761,807,280.00$9,798.13
Total dividends collected$26455115546.17M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FSGHF vs MRK ($10,000, DRIP)

YearFSGHF PortfolioFSGHF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$232,922$222,222.22$11,206$366.19+$221.7KFSGHF
2$5,086,656$4,837,429.33$12,650$502.35+$5.07MFSGHF
3$104,173,443$98,730,720.93$14,407$694.19+$104.16MFSGHF
4$2,001,166,924$1,889,701,340.37$16,585$967.82+$2001.15MFSGHF
5$36,067,485,611$33,926,237,001.88$19,342$1,363.89+$36067.47MFSGHF
6$610,050,404,477$571,458,194,873.63$22,913$1,947.19+$610050.38MFSGHF
7$9,686,139,336,337$9,033,385,403,546.24$27,662$2,823.89+$9686139.31MFSGHF
8$144,409,519,569,037$134,045,350,479,156.38$34,159$4,173.35+$144409519.53MFSGHF
9$2,022,243,856,495,371$1,867,725,670,556,501.50$43,337$6,308.80+$2022243856.45MFSGHF
10$26,607,504,688,257,330$24,443,703,761,807,280.00$56,776$9,798.13+$26607504688.20MFSGHF

FSGHF vs MRK: Complete Analysis 2026

FSGHFStock

Field Solutions Holdings Limited, a telecommunications carrier and technology company, provides connectivity and business solutions for rural, regional, and remote areas in Australia. It offers cloud computing, cloud application development, and cloud software development services. The company provides various end-to-end solutions from concept and strategy, to design, implementation, and support; and designs and builds custom software systems; establishes private and public cloud hosting services. It also designs and deploys private networks; migrates existing products and software to the cloud; manages, monitors, and optimizes cloud and network infrastructure; and builds disaster recovery scenarios. In addition, the company offers business and enterprise, government, and residential solutions, such as internet access, private network, enterprise voice solutions, and managed services; and regional access network, including fiber and fixed wireless spectrum to broadband solutions. Field Solutions Holdings Limited was incorporated in 2004 and is based in Belrose, Australia.

Full FSGHF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FSGHF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSGHF vs SCHDFSGHF vs JEPIFSGHF vs OFSGHF vs KOFSGHF vs MAINFSGHF vs JNJFSGHF vs ABBVFSGHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.